T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity

被引:1
|
作者
Canel, Marta [1 ]
Taggart, David [1 ]
Sims, Andrew H. [2 ]
Lonergan, David W. [1 ]
Waizenegger, Irene C. [3 ]
Serrels, Alan [1 ]
机构
[1] Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland
[2] Univ Edinburgh, Inst Genet & Mol Med, MRC, Canc Res UK,Edinburgh Ctr, Edinburgh, Midlothian, Scotland
[3] Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
来源
ELIFE | 2020年 / 9卷
关键词
FOCAL-ADHESION KINASE; NEXT-GENERATION; PD-1; BLOCKADE; TUMOR-CELLS; TGF-BETA; CANCER; CD80; IMMUNOTHERAPY; COSTIMULATION; PROMOTES;
D O I
10.7554/elife.48092
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Focal Adhesion Kinase (FAK) inhibitors are currently undergoing clinical testing in combination with anti-PD-1 immune checkpoint inhibitors. However, which patients are most likely to benefit from FAK inhibitors, and what the optimal FAK/immunotherapy combinations are, is currently unknown. We identify that cancer cell expression of the T-cell co-stimulatory ligand CD80 sensitizes murine tumors to a FAK inhibitor and show that CD80 is expressed by human cancer cells originating from both solid epithelial cancers and some hematological malignancies in which FAK inhibitors have not been tested clinically. In the absence of CD80, we identify that targeting alternative T-cell co-stimulatory receptors, in particular OX-40 and 4-1BB in combination with FAK, can drive enhanced anti-tumor immunity and even complete regression of murine tumors. Our findings provide rationale supporting the clinical development of FAK inhibitors in combination with patient selection based on cancer cell CD80 expression, and alternatively with therapies targeting T-cell co-stimulatory pathways.
引用
收藏
页数:23
相关论文
共 50 条
  • [11] EFFECTIVE ANTI-TUMOR IMMUNITY FOLLOWING ELIMINATION OF SUPPRESSOR T-CELL FUNCTION
    FALK, RE
    NOSSAL, NA
    FALK, JA
    SURGERY, 1978, 84 (04) : 483 - 489
  • [12] IFN-. Modulated DCsion Making on T-cell Anti-tumor Immunity
    Chang, T. H.
    Alfei, F.
    Ho, P. C.
    SWISS MEDICAL WEEKLY, 2023, 153 : 12S - 13S
  • [13] Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy
    Mantilla-Rojas, Carolina
    Velasquez, Fred C.
    Morton, Janelle E.
    Clemente, Leticia C.
    Parra, Edwin R.
    Torres-Cabala, Carlos
    Sevick-Muraca, Eva M.
    CANCERS, 2022, 14 (07)
  • [14] T-cell activation by glatiramer acetate is dependent on co-stimulation
    Ragheb, S
    Gonzales, F
    Lisak, R
    MULTIPLE SCLEROSIS, 2005, 11 : S86 - S86
  • [15] Combinatorial Antigen Targeting: Ideal T-Cell Sensing and Anti-Tumor Response
    Themelil, Maria
    Sadelain, Michel
    TRENDS IN MOLECULAR MEDICINE, 2016, 22 (04) : 271 - 273
  • [16] Co-stimulation blockade to modulate allogeneic T-cell responses
    Veith, E.
    Pilat, N.
    Wekerle, T.
    Heitger, A.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S244 - S244
  • [17] Mechanism of action of a novel agonist TNFR2 antibody that induces co-stimulation of T cells and promotes robust anti-tumor immunity
    Fulton, Ross B.
    Camblin, Adam
    Sampson, James F.
    Richards, Jennifer
    Wong, Christina
    Koshkaryev, Alexander
    Luus, Lia
    Jiao, Yang
    Xu, Lihui
    Paragas, Violette
    Razlog, Maja
    Muda, Marco
    Tam, Eric M.
    Drummond, Daryl C.
    Raue, Andreas
    CANCER RESEARCH, 2019, 79 (13)
  • [18] Transgene-enforced co-stimulation of CD4+ T cells leads to enhanced and sustained anti-tumor effector functioning
    Chang, L.
    Chang, W. C.
    McNamara, G.
    Aguilar, B.
    Ostberg, J. R.
    Jensen, M. C.
    CYTOTHERAPY, 2007, 9 (08) : 771 - 784
  • [19] Irradiated tumor cells of lipopolysaccharide stimulation elicit an enhanced anti-tumor immunity
    Li, Yuli
    Shen, Guobo
    Nie, Wen
    Li, Zhimian
    Sang, Yaxiong
    Zhang, Binglan
    Wei, Yuquan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (11) : 1815 - 1823
  • [20] Irradiated tumor cells of lipopolysaccharide stimulation elicit an enhanced anti-tumor immunity
    Yuli Li
    Guobo Shen
    Wen Nie
    Zhimian Li
    Yaxiong Sang
    Binglan Zhang
    Yuquan Wei
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 1815 - 1823